Articles on MCC and Immunotherapy
News stories on immune therapy for MCC:
NEJM Original Article on Immune Therapy for MCC: (.pdf) "PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma"
Washington Post (Page A1) story (.pdf and .pdf) by Laurie McGinley titled "The list of cancers that can be treated by immunotherapy keeps growing"
The Atlantic story (.pdf) by Vann R. Newkirk II titled "Cancer: The Final Frontier"
Fred Hutch Cancer Research Center story (.pdf) by Susan Keown titled "Finally showing hope"
Medscape story (.pdf) by Zosia Chustecka titled "Remarkable Responses in Rare MerkelCell Skin Cancer"
MedPageToday story (.pdf) by Charles Bankhead titled "Keytruda Active in Merkel Cell Cancer"
UW Medicine article (.pdf) "Immunotherapy: Hope for Merkel cell carcinoma patients"
AACR article (.pdf) "Pembrolizumab Yields Lasting Merkel-Cell Carcinoma Responses"
Johns Hopkins article (.pdf) "Immunotherapy drug shrinks tumors in half of patients with rare, virus-linked skin cancer"
TIME Article (.pdf) "A New Cancer Drug Shows Even More Promise"